Legislative Analysis
Phone: (517) 373-8080
INSULIN CO-PAY CAP http://www.house.mi.gov/hfa
House Bill 4015 as introduced Analysis available at
Sponsor: Rep. Jennifer A. Conlin http://www.legislature.mi.gov
Committee: Insurance and Financial Services
Complete to 11-8-23
SUMMARY:
House Bill 4015 would amend the Insurance Code to cap the amount insurers can charge
insured individuals for prescription insulin drugs in the state. Under the bill, any insurer
that delivers, issues for delivery, or renews a health insurance policy in Michigan would
be prohibited from requiring insured individuals to pay more than $50 for each 30-day
supply of prescription insulin drugs. The bill would apply to any health insurance policy
that is delivered, executed, issued, amended, adjusted, or renewed in Michigan (or outside
the state if it covers a Michigan resident) beginning 90 days after the bill is enacted.
The bill states that it would not prevent an insurer from reducing the cost of insulin to
insured individuals by an amount greater than $50.
Proposed MCL 500.3406z
FISCAL IMPACT:
House Bill 4015 would not have a fiscal impact on any state or local government units.
Legislative Analyst: Alex Stegbauer
Fiscal Analyst: Marcus Coffin
■ This analysis was prepared by nonpartisan House Fiscal Agency staff for use by House members in their
deliberations and does not constitute an official statement of legislative intent.
House Fiscal Agency Page 1 of 1


Statutes affected:
Substitute (H-4): 500.100, 500.8302
House Introduced Bill: 500.100, 500.8302